Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk

Berg, 1963, A new serum type system in man – the LP system, Acta Pathol Microbiol Scand, 59, 369, 10.1111/j.1699-0463.1963.tb01808.x Danesh, 2000, Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies, Circulation, 102, 1082, 10.1161/01.CIR.102.10.1082 Erqou, 2009, Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, JAMA, 302, 412, 10.1001/jama.2009.1063 Kamstrup, 2008, Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study, Circulation, 117, 176, 10.1161/CIRCULATIONAHA.107.715698 Kronenberg, 2013, Lipoprotein(a): resurrected by genetics, J Intern Med, 273, 6, 10.1111/j.1365-2796.2012.02592.x Utermann, 2001, Lipoprotein(a), 2753 Seed, 1990, Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia, N Engl J Med, 322, 1494, 10.1056/NEJM199005243222104 Sandholzer, 1992, Apo(a) isoforms predict risk for coronary heart disease. A study in six populations, Arterioscler Thromb, 12, 1214, 10.1161/01.ATV.12.10.1214 Kamstrup, 2009, Genetically elevated lipoprotein(a) and increased risk of myocardial infarction, JAMA, 301, 2331, 10.1001/jama.2009.801 Clarke, 2009, Genetic variants associated with Lp(a) lipoprotein level and coronary disease, N Engl J Med, 361, 2518, 10.1056/NEJMoa0902604 Kamstrup, 2010, Lipoprotein(a) and ischemic heart disease – a causal association? A review, Atherosclerosis, 211, 15, 10.1016/j.atherosclerosis.2009.12.036 Klein, 2008, Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area, Arterioscler Thromb Vasc Biol, 28, 1851, 10.1161/ATVBAHA.108.169292 Umahara, 2011, Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques, Atherosclerosis, 215, 392, 10.1016/j.atherosclerosis.2010.10.048 Kamstrup, 2012, Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis, Arterioscler Thromb Vasc Biol, 32, 1732, 10.1161/ATVBAHA.112.248765 Caplice, 2001, Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis, Blood, 98, 2980, 10.1182/blood.V98.10.2980 Deb, 2004, Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis, Clin Cardiol, 27, 258, 10.1002/clc.4960270503 Nordestgaard, 2010, Lipoprotein(a) as a cardiovascular risk factor: current status, Eur Heart J, 31, 2844, 10.1093/eurheartj/ehq386 Langsted, 2008, Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction, Circulation, 118, 2047, 10.1161/CIRCULATIONAHA.108.804146 Mora, 2008, Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events, Circulation, 118, 993, 10.1161/CIRCULATIONAHA.108.777334 Steiner, 2011, Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study, Pediatrics, 128, 463, 10.1542/peds.2011-0844 Sidhu, 2012, Fasting time and lipid levels in a community-based population: a cross-sectional study, Arch Intern Med, 172, 1707, 10.1001/archinternmed.2012.3708 Cohn, 1991, Plasma lipoprotein distribution of apolipoprotein(a) in the fed and the fasted state, Atherosclerosis, 90, 59, 10.1016/0021-9150(91)90244-W Dursunoglu, 2005, Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation, Rheumatol Int, 25, 241, 10.1007/s00296-004-0438-0 Wang, 2008, Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation, Clin Chim Acta, 390, 67, 10.1016/j.cca.2007.12.015 Zimmermann, 1999, Inflammation enhances cardiovascular risk and mortality in hemodialysis patients, Kidney Int, 55, 648, 10.1046/j.1523-1755.1999.00273.x Nordestgaard, 2007, Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women, JAMA, 298, 299, 10.1001/jama.298.3.299 Seman, 1986, Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a), Biochem Cell Biol, 64, 999, 10.1139/o86-133 Kronenberg, 1998, Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a), Kidney Int, 54, 1385, 10.1046/j.1523-1755.1998.00086.x Reiner, 2011, ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158 Nordestgaard, 2012 Boerwinkle, 1992, Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations, J Clin Invest, 90, 52, 10.1172/JCI115855 Kraft, 1992, The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration, Hum Genet, 90, 220, 10.1007/BF00220066 Marcovina, 1996, Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature, Clin Chem, 42, 436, 10.1093/clinchem/42.3.436 Sandholzer, 1991, Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups, Hum Genet, 86, 607, 10.1007/BF00201550 Mensink, 1992, Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans, J Lipid Res, 33, 1493, 10.1016/S0022-2275(20)41404-X Nestel, 1992, Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet, J Lipid Res, 33, 1029, 10.1016/S0022-2275(20)41418-X Cohn, 1988, Postprandial plasma lipoprotein changes in human subjects of different ages, J Lipid Res, 29, 469, 10.1016/S0022-2275(20)38520-5 Mihas, 2011, Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis, Curr Vasc Pharmacol, 9, 271, 10.2174/157016111795495530 Bansal, 2007, Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women, JAMA, 298, 309, 10.1001/jama.298.3.309 Anuurad, 2008, High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans, J Clin Endocrinol Metab, 93, 1482, 10.1210/jc.2007-2416 Noma, 1994, Lp(a): an acute-phase reactant?, Chem Phys Lipids, 67–68, 411, 10.1016/0009-3084(94)90164-3 Slunga, 1992, Lipoprotein(a) and acute-phase proteins in acute myocardial infarction, Scand J Clin Lab Invest, 52, 95, 10.3109/00365519209088771 Maeda, 1989, Transient changes of serum lipoprotein(a) as an acute phase protein, Atherosclerosis, 78, 145, 10.1016/0021-9150(89)90218-9 Min, 1997, Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease, Clin Chem, 43, 1891, 10.1093/clinchem/43.10.1891 Kargman, 1998, Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study, Atherosclerosis, 139, 391, 10.1016/S0021-9150(98)00085-9 Thanassoulis, 2013, Genetic associations with valvular calcification and aortic stenosis, N Engl J Med, 368, 503, 10.1056/NEJMoa1109034 Zacho, 2008, Genetically elevated C-reactive protein and ischemic vascular disease, N Engl J Med, 359, 1897, 10.1056/NEJMoa0707402